7-(4-bromobutoxy)-3,4-dihydro-2(1H)-quinolinone

HCID 10542064

Grundinformationen

CAS
129722-34-5
Standard-SMILES
O=C1CCc2ccc(OCCCCBr)cc2N1
InChIKey
URHLNHVYMNBPEO-UHFFFAOYSA-N
Summenformel
C13H16BrNO2
Durchschnittliche Molmasse
298,18 g/mol
Monoisotopische Masse
297,03644085

Namen und Bezeichner

Bevorzugter Name
7-(4-bromobutoxy)-3,4-dihydro-2(1H)-quinolinone
IUPAC
7-(4-bromobutoxy)-3,4-dihydro-1H-quinolin-2-one
Englischer Name
3,4-Dihydro-7-(4-bromobutoxy)-2(1H)-quinolinone
Summenformel
C13H16BrNO2
Molmasse
298.18

Namen und Synonyme

129722-34-57-(4-Bromobutoxy)-3,4-dihydro-2(1H)-quinolinoneRefChem:545124603-356-07-(4-bromobutoxy)-3,4-dihydroquinolin-2(1H)-one3,4-Dihydro-7-(4-bromobutoxy)-2(1H)-quinolinone7-(4-Bromo-butoxy)-3,4-dihydro-1H-quinolin-2-one7-(4-bromobutoxy)-3,4-dihydro-1H-quinolin-2-one7-(4-bromobutoxy)-3,4-dihydro-2-quinolinone2(1H)-Quinolinone, 7-(4-bromobutoxy)-3,4-dihydro-7-(4-bromobutoxy)-3,4-dihydroquinolin-2-oneMFCD06658540
Weitere Namen anzeigen
Aripiprazole Bromobutoxyquinoline Impurity7-(4-Bromobutoxy)-2(1h)-3,4-DihydroquinolinoneCL041Aripiprazol IntermediateAripiprazole Impurity iAripiprazole impurities17757-(4-bromobutoxy)-3,4-dihydro-7-(4-BROMOBUTOXY)-3 4-DIHYDROCARBOSTYRYL
Aripiprazole Bromo Impurity7-(4-Bromobutoxy)-3,4-DihydroquinolinoneSB326727-(4bromobutoxy)-3,4-dihydrocarbostyrilSY0235857-(4-bromobutoxy)-3,4-dihydrocarbostyrilF2135-0630(1H)-7-(4'-BROMOBUTOXY)-3,4-DIHYDRO-2-QUINOLINONE

Datenbank-Bezeichner

CAS
129722-34-5
PubChem CID
10542064
DTXSID
DTXSID00441550
UNII
4SR329TWJ9
EC Number
603-356-0
Nikkaji
J2.556.704H

Eigenschaften

Berechnete Struktureigenschaften

XLogP
2,5
Polarare Oberfläche (TPSA)
38,3 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
5
Schwere Atome
17

Physikochemische Eigenschaften

Schmelzpunkt
110 · 110-111°C
Siedepunkt
463.4 · 463.4±45.0 °C(Predicted)
Dichte
1.383 · 1.383±0.06 g/cm3(Predicted)
storage temp.
Sealed in dry,Room Temperature
Löslichkeit
Chloroform (Slightly), Methanol (Slightly)
pka
14.41 · 14.41±0.20(Predicted)

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 25% (1 of 4) of reports.

Warning

H315 (50%): Causes skin irritation [Warning Skin corrosion/irritation]

P203, P261, P264, P264+P265, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 4 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationStatus: Active Update: 12-06-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/25972
Hazard Classes and CategoriesSkin Irrit. 2 (50%)

Sicherheitsdaten

hs_code
2933499090

Chemie und Industrie

Anwendungen

VerwendenAn impurity in the synthesis of Aripiprazole (A771000). A degradation product in Aripiprazole tablets.

Anbieter100 Anbieter

梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
Career Henan Chemica Co+86-0371-86658258 +86-13203830695 · [email protected]
济南百隆化学有限公司[email protected] · [email protected]
广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]

Zugehörige Reaktionen

20

Notizen zur Verbindung

Wird geladen…